Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 25, 2025 08:30 ET | Source: InvestorBrandNetwork (IBN)

IBN Initiates Coverage of Soligenix Inc.

AUSTIN, Texas, March 25, 2025 (GLOBE NEWSWIRE) -- via IBN – Soligenix Inc. (NASDAQ: SNGX), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare...
October 24, 2024 07:30 ET | Source: Soligenix, Inc.

Soligenix, Inc. to Present at the 2024 ThinkEquity Conference

Soligenix, Inc. to Present at the 2024 ThinkEquity Conference
August 01, 2024 09:00 ET | Source: PRISM Mediawire

Strong Clinical Momentum for Soligenix's HyBryte™ in Treating Cutaneous T-Cell Lymphoma; PCG Digital Exclusive with Dr. Brian Poligone

Strong Clinical Momentum for Soligenix's HyBryte™ in Treating Cutaneous T-Cell Lymphoma; PCG Digital Exclusive with Dr. Brian Poligone
July 15, 2024 10:16 ET | Source: PRISM MarketView

PRISM MarketView Features Q&A with Dr. Ellen Kim: Soligenix's HyBryte™— Lighting the Way Towards Commercial Success with Promising FLASH Study Results

PRISM MarketView Features Q&A with Dr. Ellen Kim: Soligenix's HyBryte™— Lighting the Way Towards Commercial Success with Promising FLASH Study Results
June 05, 2024 08:00 ET | Source: PRISM MarketView

Setting the Stage for Success: PRISM MarketView Highlights Soligenix's Promising HyBryte™ Replication Trial

Setting the Stage for Success: PRISM MarketView Highlights Soligenix's Promising HyBryte™ Replication Trial
May 21, 2024 12:35 ET | Source: PRISM MarketView

PRISM MarketView Highlights Soligenix, Inc. as it Builds on Compelling Phase 3 Data with Key Catalysts on the Horizon

PRISM MarketView Highlights Soligenix, Inc. as it Builds on Compelling Phase 3 Data with Key Catalysts on the Horizon
October 17, 2022 10:16 ET | Source: FMW Media Works Corp

UPDATE: New to The Street to Feature Soligenix Appearances on Its Syndicated Televised Outlets

NEW YORK, Oct. 17, 2022 (GLOBE NEWSWIRE) -- FMW Media Inc.'s New to The Street is pleased to announce that Soligenix, Inc. (Nasdaq: SNGX), a late-stage biopharmaceutical company focused on...
October 17, 2022 08:30 ET | Source: FMW Media Works Corp

New to The Street to Feature Soligenix Appearances on Its Syndicated Televised Outlets

NEW YORK, Oct. 17, 2022 (GLOBE NEWSWIRE) -- FMW Media Inc.'s New to The Street is pleased to announce that Soligenix, Inc. (Nasdaq: SNGX), a late-stage biopharmaceutical company focused on...